Geode Capital Management LLC Increases Stock Position in Utah Medical Products, Inc. (NASDAQ:UTMD)

Geode Capital Management LLC lifted its holdings in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 9.6% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 97,080 shares of the medical instruments supplier’s stock after purchasing an additional 8,516 shares during the period. Geode Capital Management LLC owned about 2.86% of Utah Medical Products worth $6,497,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of UTMD. Minerva Advisors LLC increased its position in Utah Medical Products by 461.8% during the third quarter. Minerva Advisors LLC now owns 42,328 shares of the medical instruments supplier’s stock worth $2,818,000 after buying an additional 34,794 shares in the last quarter. State Street Corp increased its position in Utah Medical Products by 0.9% during the 3rd quarter. State Street Corp now owns 80,856 shares of the medical instruments supplier’s stock worth $5,434,000 after purchasing an additional 694 shares in the last quarter. Brandes Investment Partners LP raised its stake in Utah Medical Products by 66.2% in the 2nd quarter. Brandes Investment Partners LP now owns 116,524 shares of the medical instruments supplier’s stock valued at $7,789,000 after purchasing an additional 46,427 shares during the last quarter. BNP Paribas Financial Markets lifted its holdings in Utah Medical Products by 102.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,117 shares of the medical instruments supplier’s stock valued at $75,000 after purchasing an additional 566 shares in the last quarter. Finally, American Century Companies Inc. boosted its stake in shares of Utah Medical Products by 18.1% during the 2nd quarter. American Century Companies Inc. now owns 11,921 shares of the medical instruments supplier’s stock worth $796,000 after purchasing an additional 1,830 shares during the last quarter. 69.60% of the stock is currently owned by institutional investors and hedge funds.

Utah Medical Products Price Performance

Shares of Utah Medical Products stock opened at $61.35 on Friday. Utah Medical Products, Inc. has a fifty-two week low of $60.39 and a fifty-two week high of $85.76. The business’s fifty day moving average is $64.06 and its two-hundred day moving average is $66.17. The firm has a market cap of $208.10 million, a PE ratio of 14.37 and a beta of 0.08.

Utah Medical Products Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, January 3rd. Investors of record on Monday, December 16th were given a dividend of $0.305 per share. The ex-dividend date was Monday, December 16th. This is an increase from Utah Medical Products’s previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a yield of 1.99%. Utah Medical Products’s dividend payout ratio is 28.57%.

Analyst Ratings Changes

Separately, StockNews.com lowered shares of Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research report on Thursday, November 7th.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.